ArticleFrontiers in psychiatry2025
High frequency repetitive transcranial magnetic stimulation for auditory verbal hallucinations in schizophrenia-spectrum disorders: a naturalistic study.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigates the efficacy of high frequency repetitive transcranial magnetic stimulation (rTMS) for auditory verbal hallucinations in patients with schizophrenia spectrum disorders in routine clinical practice. Methods: In this monocentric study, data were collected on patients with schizophrenia treated by rTMS for resistant auditory verbal hallucinations from May 2020 to May 2024. Treatment efficacy was regularly assessed. Results: The data of 65 patients were collected. There was a significant improvement in the Auditory Hallucination Rating Scale (AHRS, Conclusion: These data show the clinical interest and the good tolerance of rTMS in daily practice in patients with schizophrenia suffering from auditory verbal hallucinations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.